Neurizon Therapeutics: FDA affirms Healey ALS platform trial
The U.S. Food and Drug Administration has affirmed Neurizon Therapeutics Ltd's ongoing Healey ALS Platform Trial as potentially registrational.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA affirms Neurizon Therapeutics' Healey ALS trial
The U.S. Food and Drug Administration has affirmed Neurizon Therapeutics Ltd's ongoing Healey ALS Platform Trial.